Health Canada authorized Lynkuet for menopausal VMS
Lynkuet 60 mg capsules were authorized after a New Drug Submission by Bayer Inc. for moderate to severe vasomotor symptoms associated with menopause.
source: Drug and Health Products Portal
The full briefing is in the app.